Nicoletta Urbano graduated in Pharmacy at the Faculty of Pharmacy of the University of Bologna (Italy) with the experimental thesis in Radiochemistry entitled "Radiolabelled monoclonal antibodies in diagnosis and in therapy". She obtained the Specialization with honors in “Hospital Pharmacy” discussing the thesis entitled "Phosphonates marked with Samarium-153 in the pain treatment of bone metastases" in 2005, Faculty of Pharmacy of the University of Bologna.
She obtained the Radiopharamcy Certificate “European postgraduate education of the person in charge of small-scale production and quality control of radiopharmaceuticals” in 2005 (European Association of Nuclear Medicine) and AIFA Certified for the qualification as Qualified Person in 2015.
Currently, she worked as Radiopharmacist at the U.O.C. of Nuclear Medicine of the University Hospital “Fondazione Policlinico Tor Vergata” (Rome, Italy).
She is the author of more of then sixty scientific publications, including published works in international journal with Impact Factor, books, communications and posters at national and international scientific congresses. Thesis supervisor of over 20 Degree and Specialization Theses focused on Radiopharmacy.
Teaching activity in Radiopharmaceuticals in:
• University Master (University of Palermo (Italy), Campus-Biomedic University of Rome and University of Rome Tor Vergata);
• Post-graduate high-level training course (University of Padova, Italy);
• Degree course in Medical Radiology Techniques, Imaging and Radiotherapy (University of Foggia and University of Rome Tor Vergata);
She gained experience in Italian and foreign Clinical Centers including the Nuclear Medicine Department of the Garden State Cancer Center of Belleville (New Jersey, USA) where she learned new methods for conjugation and radiolabelling of active biomolecules.
Main research interest: Radiopharmacy, Molecular Imaging, Radiolabeling procedure of peptides, monoclonal antibody, blood cells, active biomolecules with gamma, beta and alpha nuclides, Validation and quality control of PET, SPECT and Therapy radiopharmaceuticals, Radioimmunoassays, Diagnostic Imaging and Anatomic Pathology in Personalized Medicine, Management and guidance of quality assurance in nuclear pharmacy lab, Development and formulation of research protocols, Implementation of communication and training interventions in the field of radiopharmacy.